Antiinfective medicine use in Australia experienced notable fluctuations over the past decade with a peak usage in 2014 and a marked decline by 2020, attributed to heightened hygiene practices and reduced infection rates during the COVID-19 pandemic. The value stood at 19.7 Defined Daily Dosages per Thousand Persons per Day in 2023, reflecting a slight recovery from the mid-pandemic drop.
Over the last two years, year-on-year variation showed growth: a 13.02% increase in 2022 followed by a 3.14% increase in 2023. The average annual variation (CAGR) over the last 5 years from 2018 to 2023 indicates a recovery trend with a small positive growth rate of 0.2%.
Forecasts predict a slight decline in usage, with a 5-year CAGR of -0.52% from 2024 to 2028. Emerging trends to watch include the influence of new health policies, antibiotic resistance, and innovations in antiinfective treatments.
